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It has been known for more than  five years that epidermal Langerhans cells 
(LC) 1  are Ia  + leukocytes that can provide accessory cell function for T  lymphocyte 
responses (reviewed in  1). Recent studies (2) of LC in culture have established a 
close  relationship  to  the  immunostimulatory  dendritic  cells  within  lymphoid 
organs.  Specifically,  LC  behave  as  immature  or  precursor  elements  in  the 
dendritic cell family. 
In  1983, we and others (3, 4) simultaneously encountered a previously unrec- 
ognized cell within murine epidermis that was Ia-, dendritic, lacked the Birbeck 
granules of LC, and had large amounts of Thy-1 antigen (in contrast to the low 
amounts  on  most  keratinocytes;  3,  5).  Like  LC,  these  Thy-1 + epidermal  cells 
(Thy-1 +  EC)  carried  the  Ly-5  leukocyte common  antigen  (3)  and  were  bone 
marrow derived (6, 7). The question then arose whether Thy-1 ÷ EC are precur- 
sors to Ia  + LC, particularly since Thy-1 is an antigen found on immature cells in 
several lymphoid and  myeloid lineages (8,  9),  or do they represent a  different 
lineage? 
Here we have used electron microscopy (EM), cytochemistry, and a large panel 
of  monoclonal  antibodies  (mAb)  to  show  that  Thy-1 ÷  cells  are  thoroughly 
different from LC.  In  fact, Thy-1  cells resemble only natural  killer (NK) cells 
and  no other  known  class  of leukocyte.  The phenotyping we  describe  should 
provide a  means for their enrichment and functional characterization. 
Materials and Methods 
Mice.  C3H/He, C57BL/6, and B6.H-2k mice of both sexes, 6-12 wk old, were from 
The Trudeau Institute, Saranac Lake, NY or the Bundesanstalt for Versuchstieranstalt, 
Himberg, Austria. For selected purposes, we used CBA, C57BL/6 (bg/+), and C57BL]6 
(bg/bg) mice from The Jackson Laboratory, Bar Harbor, ME; WBB6 F1/J (W]WV), AKR, 
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1  Abbreviations used in this paper: EC, epidermal cell; EM, electron microscopy; FITC, fluorescein 
isothiocyanate; LC, Langerhans cell; mAb, monoclonal antibody; NK, natural killer; PAP, peroxidase 
antiperoxidase; PBS, phosphate-buffered saline; RITC, rhodamine isothiocyanate; Thy-1  ÷ EC, Thy- 
1-bearing dendritic epidermal cell. 
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and  SJL  from Olac,  1976  Ltd.,  Bicester,  England;  BALB/cAn from  The  Rockefeller 
University; and A/J from Dr. Mazuzko, Institut ffir Krebsforschung, Vienna, Austria. 
Preparations of Mouse Ear Epidermis.  Epidermal  sheets  were  used  to  immunostain 
leukocytes in situ,  rather than 8-#m frozen sections, which were much less sensitive (see 
Results).  Sheets  were peeled  from mouse ear skin treated  with ammonium thiocyanate 
(10), rinsed in phosphate-buffered saline (PBS), fixed in acetone at room temperature for 
20 rain,  rinsed again, and stained with antibodies.  Alternatively (see below), epidermal- 
dermal separation was achieved with dispase (I 1). 
Semithin cryosections were used also.  Ear skin was prefixed in Nakane's fixative (12) 
for 60 min and soaked in 2.3 M sucrose in PBS for 60 min, and 200-nm frozen sections 
were  cut  at  -100°C  with  an  ultramicrotome  equipped  with  an  FC-4  cryoattachment 
(Ultracut;  Reichert,  Vienna).  Sections were processed as described  (13) and stained  for 
Thy-1 and Ia with a three-step immunofluorescence technique (see below). EC suspensions 
were prepared by a trypsinization method (2) or, for selected purposes, with dispase (2). 
Immunolabeling Techniques.  Our antibody panel is described in Table I. All antibody 
dilutions and washes were in PBS-3% bovine plasma albumin-0.04% sodium azide except 
that azide was omitted for peroxidase-labeled reagents. Antibodies were tested at saturat- 
ing or supersaturating  levels and,  if need be,  positive controls were run  on  single-cell 
suspensions  of spleen,  peritoneal  cells,  bone  marrow,  and  thymus.  Negative  controls 
included replacement of the first antibody with unrelated or unreactive antibodies of the 
same isotype, e.g., anti-la  b'd on H-2k mice. Antibodies were considered unreactive only if 
staining  was  not  observed  using  all  immunolabeling  techniques,  with  both  epidermal 
TABLE  I 
Description of Primary (First-Step) Antibodies 
Specificity*  Clone  Ig*  Reference  Source  I  Specificity*  Clone  Ig*  Reference  Source j 
Thy- 1.2  5a-8  mlgG2b  --  AS  la  k  I 1-5.2  mlgG2b  27  BD 
Thy- 1.2  30-H 12  rlgG2b  25  BD  la  k~  10-2.16  mlgG2b  28  ATCC 
Thy- 1.2  B5-3  rlgG2b  26  RS  la  bA  B21-2  rlgG2b  26  RS 
Lyt-I  53-7.3  rlgG2a  35  ATCC  H-2D d  B25-1  rlgG2a  26  RS 
Lyt-l.l  --  mlgG2b  --  NEN  H-2K ~  --  mlgG2a  27  BD 
Lyt-l.2  --  mlgG2b  --  NEN 
Lyt-2  53-6.7  rlgG2a  25  BD  LCA  Ly-5.]  mlgG2a  --  NEN 
Lyt-2.1  --  mlgG2b  --  NEN  LCA  MI/S4  rlgG2a  29  HT 
Lyt-2.2  --  mlgM  --  NEN 
Lyt-3.2  --  mlgM  --  NEN  Macropbage  F4/80  rlgG2b  37  JA 
L3T4  GK 1.5  rlgG2b  30  FF  FcR  2.4G2  rIgG  38  JU 
TL  TL.m4  mlgG2a  --  NEN  C3biR  1.21J  rlgG2a  26  JU 
ll-2 R  7D4  rIgM  31  ES  C3biR  MI/70  rlgG2b  39  ATCC 
1L-2 R  3C7  rlgG  31  ES  DC  33D 1  rlg(;  40  RS 
T, thymus  H-I 1  rlgG2b  25  HM  asGM1  --  rabbit  41  GS 
[gpI00  M5/113  rlgG2a  25  HT  NKI.I  PK136-3-6  mlgG2b  42  GK 
T, B  H9/25  mlgM  43  SL  SI00  --  rabbit  --  Dako 
NK, T  Qat-4  mlgM  32  CLS  HSA  M 1/69.16  rlgG2h  44  HT 
NK, T  Qat-5  mlgM  32  CLS  I-J  k  WF8.C.12.8  mlgG  45  CW 
Lyre-10.1  $3.214  mlgM  33  UH  I-J  ~  --  alloAb  --  AS 
Lyre-18.1  $8.261  mlgM  34  UH  Bcell  TIBI45  rlgM  46  ATCC 
Lyre-19.2  KI0.6  mlgG2b  35  UH  Bcell  TIBI46  rlgM  47  ATCC 
Lym-22.2  T28.45  mlgG2b  36  UH  Mast cell  B23.1  rlgM  48  PL 
* C3biR, C3bi receptor;  DC,  spleen  dendritic cell;  FcR,  Fc receptor; asGMl, asialo  GMI; HSA, heat-stable  antigen; IL-2R,  interleukiri  2 
receptor;  LCA, leukocyte  common antigen. 
* r, Rat; m, mouse. 
! Commercial  sources:  AS,  Accurate  Chemical  & Scientific  Corp.  (Cedarlane);  ATCC, American Tissue Culture Collection;  BD,  Becton, 
Dickinson & Co.; CLS, Camon Labor Service;  HT, Hybritech Inc.;  NEN,  New England Nuclear;  SL, Sera  Labs. Individual  sources: CW, C. 
Waltenbaugh, University of Chicago;  ES. E. Shevach,  NIH, Bethesda,  MD; FF, F. Fitch,  University  of Chicago;  GK, G. Koo, Merck & Co., 
Rahway, NJ; GS, G. Schwarting,  Waltham, MA; HM, H. Morse,  NIH, Bethesda,  MD;JA, J. Austyn, Oxford University;  JU,J. Unkele~, The 
Rockefeller  University; PL,  P.  LeBlanc;  University of Alabama at Birmingham; RS,  R.  Steinman,  The Rockefeller  University; UH, U. 
Hammerling, Sloan-Kettering Cancer Institute, New York. 1370  THY-1 ÷ MURINE EPIDERMAL  CELLS 
suspensions and sheets (acetone fixed or unfixed; prepared with dispase or with ammonium 
thiocyanate). 
For staining of sheets,  the first antibody was applied for  16  h  at 4°C  with constant 
shaking.  The  sheets  were  washed and  exposed 90-180  min  at  37°C  with  one of the 
following: affinity-purified F(ab')2 goat anti-mouse IgG and IgM; fluorescein or rhoda- 
mine isothiocyanate (FITC, RITC) conjugates (Grub antibodies; Scandic, Vienna) at 20 
#g/ml; FITC-goat F(ab')~ anti-rat IgG at 1:20 (U.S. Biochemical Corp., Cleveland, OH); 
Texas  Red-labeled,  affinity-purified goat  F(ab')~ anti-rat  IgG at  I0  #g/mi  (Jackson 
Immunoresearch Lab, Inc., Avondale, PA). For three-step staining, the first rat or mouse 
mAb was followed by an  affinity-purified, polyclonal mouse anti-rat  Ig (5-10  #g/ml; 
provided by Dr. E. Havell and Dr. G. Spitalny, The Trudeau Institute) or rat anti-mouse 
Ig (1:100; Jackson Immunoresearch Lab, Inc.), and then FITC or RITC conjugates (90 
min, 37°C), as above. Double labeling with anti-Thy-1 or anti-Ia and a second mAb was 
performed as described (2).  For anti-Thy-1/anti-asialo GMI double  labeling,  we used 
FITC-anti-Thy-  1.2 (Becton, Dickinson & Co., Oxnard, CA) at 1:100, followed by affinity- 
purified rabbit anti-asialo GM~ at 1:100 and species-specific, Texas Red-labeled donkey 
anti-rabbit Ig at  1:50 (Amersham Corp., Arlington Heights, IL). Sheets were mounted 
in  PBS/glycerol/azide,  dermal  side  up,  and  viewed with  Leitz  Ortholux  II or  Nikon 
Optiphot fluorescence microscopes. 
EC suspensions were stained on ice, 30-60 min per step, using the same immunofluo- 
rescence reagents as for sheets. For anti-S100, B6.H-2k cells in suspension were exposed 
to biotin anti-Thy-1 or anti-Ia  k (1:50; Becton, Dickinson & Co.) followed by Texas Red- 
streptavidin (1:100; Amersham Corp.). The cells were cytospinned, fixed in acetone for 
5  min, and incubated with rabbit anti-S100 at  1:200  (Dako Corp.,  Santa Barbara, CA) 
followed by species-specific,  FITC-labeled donkey  anti-rabbit  Ig at  1:40  (Amersham 
Corp.). Controls used normal rabbit serum and omitted anti-S100. 
Two immunoperoxidase techniques gave similar results. For peroxidase antiperoxidase 
(PAP) (14), sheets were exposed to 1% normal goat serum for 30 rain at room temperature; 
primary antibody for 16 h at 4°C;  goat anti-mouse IgG (I:10; Tago Inc., Burlingame, 
CA) or goat anti-rat IgG (1:20; Nordic Labs, Tilburg, Holland) as link antibodies for 90 
min at 37°C; and finally the respective PAP complex for 90 min at 37°C (mouse PAP, 
50 gg/ml, Arnel,  New York; rat PAP, 50 #g/ml, Accurate Chemical & Scientific Corp., 
Westbury, NY). After washing, sheets were stained with diaminobenzidine-H202 (15) for 
30 min at room temperature in the dark followed by 0.5%  CuSO4 enhancement for 5 
min at room temperature. Sheets were mounted in PBS-glycerol. For the second avidin- 
biotin-peroxidase complex technique (16), we used a Vectastain kit as prescribed by the 
manufacturer (Vector Laboratories, Inc., Burlingame, CA). 
For immuno-EM of unfixed EC suspensions, we used two-step methods (2) with either 
peroxidase-labeled, F(ab')2 goat anti-mouse IgG (Thy-1) or goat anti-rabbit IgG (anti- 
asialo GM1), both from Tago, Inc. To label EC in situ, dispase sheets (11) were fixed with 
periodate-lysine-paraformaldehyde (12). 
Cytochemistry.  Sheets were stained for ATPase (17).  EC suspensions were used for EM 
demonstration of a-naphthylbutyrate (Sigma Chemical Co., St. Louis, MO) esterase (18); 
acid phosphatase (19) (sodium/3-glycerophosphate as substrate; grade I, Sigma Chemical 
Co.); and arylsulfatase B (20) with Goldfischer's reaction medium (21) and p-nitrocatechoi 
sulfate (Sigma Chemical Co.) as substrate. For some experiments, EM cytochemistry was 
combined with anti-Thy-1  immunogoid labeling. Cells were exposed for 60 min on ice 
with mouse mAb anti-Thy-1.2 (1:500; Cedarlane Laboratories Limited, Toronto, Canada) 
followed by goat anti-mouse  IgG/20 nm  colloidal  gold conjugate (1:20; Janssen  Life 
Sciences, Beers, Belgium) either before (acid hydrolase) or after (nonspecific esterase) the 
cytochemical procedure. ROMANI  ET  AL.  1371 
Results 
Light and Electron Microscopy of Thy-1 + EC 
Epidermal  sheets  rather  than  cryostat  sections  proved  to  be  much  more 
sensitive  for  the  localization  of Thy-1  and  Ia  antigens.  Both  antigens  were 
visualized using directly labeled mAb or two-step indirect immunofluorescence. 
In cryostat sections, triple-layer methods failed to identify most Thy-1 + and Ia  + 
cells, although these cells were readily apparent if sheets were stained first and 
then cryostat sections made (not shown). After indirect immunofluorescence or 
peroxidase techniques,  epidermal sheets contained a  regular system of Thy-1  + 
and Ia  + cells, each with a  robust array of dendrites (Fig.  1).  The Thy-1 and Ia 
markers never overlapped, but both were distributed in a  homogenous pattern, 
usually adjacent to one another (see below). A  few (<5%) of the LC stained very 
strongly with anti-Ia, sometimes in clusters (Fig.  1); by immuno-EM, the typical 
features of LC (1) were apparent (not shown). Thy-1 + EC were found in normal 
numbers in epidermal sheets from mast cell-deficient W/W  v mice (22). 
By immuno-EM,  all Thy-1 + EC (Fig.  2) lacked Birbeck granules and instead 
exhibited distinctive, membrane-bound granules that had an electron-dense core 
surrounded by less electron-dense material, occasionally including small vesicles. 
All mouse strains, including C57BL/6 bg/+, had similar granules, but beige (bg/ 
bg)  Thy-1  cells  had  only  a  few  very  large  granules  (Fig.  2).  Typically,  the 
FIGURE  1.  Immunolocalization of Thy-1 and Ia in murine ear epidermal sheets: (A, B). Thy- 
1  + EC. The highly dendritic shape is seen if sensitive techniques are used (PAP; C57BL/6 
mice). (A) x  140. (B) X 900. (C, D) la  + EC. At low power a subfraction of strongly la  + cells, 
here in a cluster, is on the right (indirect immunofluorescence, C3H mice) while, at higher 
power, the strongly Ia  + cell is on the left (ABC technique, C57BL/6 mice). (C) x  140. (D) X 
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lysosomes of bg/bg mice are enlarged in many cell types,  including NK cells,  so 
the granules of Thy-1 + cells may be lysosomes (23). 
Immunofluorescence of semithin sections showed that the Thy-1 ÷ EC, like LC, 
were located in the basal layer (Fig.  3).  By immuno-EM, small amounts of Thy- 
1 were seen on most keratinocytes,  especially in lower layers (Fig.  3). 
Cytochemistry 
Double-labeling  experiments  indicated  that Thy-1 + EC did  not overlap with 
the ATPase + LC network (1). Acid phosphatase was found in the Golgi of Thy- 
1  +  EC,  but  was  absent  from  most  (>90%)  of the  granules  (data  not  shown). 
Another  hydrolase,  arylsulfatase,  was  found  in  most  granules  (Fig.  4).  Both 
enzymes were present in the Golgi and a  few lysosomes of LC, as described for 
man (24). 
FIGURE 3.  Intraepidermal localization of Thy-1 ÷ EC (C3H).  (A) lmmunoperoxidase at the 
EM  level of dispase sheets.  At low  power (A1) the Thy-1 + cell and a  process (arrow) stain 
strongly and are localized to the basal layer along with LC. At higher magnification, the typical 
granules of LC (A2, arrows) and Thy-1 + EC (A3) are evident, x  4,600 (A1); x  28,500 (A2, 3); 
scale bar =  1 #m.  (B) Semithin cryosection stained for Thy-1  by a  triple layer, fluorescence 
method. Dotted line marks the epidermal-dermal junction. Two Thy-1 ÷ EC (arrows) are seen 
in the basal layer as well as Thy-1 ÷ fibroblasts in the dermis, x  360. 
FIGURE 2.  Ultrastructure ofThy- 1  + EC: Thy- 1  + cells (C3H) were identified in EC suspensions 
using anti-Thy-1 mAb followed by peroxidase F(ab')2 goat anti-mouse IgG and diaminoben- 
zidine cytochemistry. Bar =  1 #m. (A) Overview of a Thy-1 ÷ cell (inset shows the immunocy- 
tochemical reaction product) to show the villous surface, lobulated nucleus, dense cytoplasm, 
and characteristic granules (arrows).  X  14,900.  Inset, x  51,000. (B) Golgi region of another 
Thy-1 ÷ cell to demonstrate the distinctive membrane-bound granules that have an electron- 
dense core (arrowheads) and/or content of vesicles (arrows). x  51,000. (C) Enlarged granules 
occur in Thy-1 + EC from beige mice (bg/bg). Same magnification as in B, ×  51,000. 1374  THY-1  ÷ MURINE  EPIDERMAL CELLS 
FIGURE 4.  EM arylsulfatase combined with Thy-1 immunogold labeling (C3H) (A) Gold 
granules mark the Thy-1 surface antigen and dark spots the cytoplasmic  arylsulfatase reaction 
product,  x  12,600. Areas 1, 2, and 3 are shown at higher power in the respective insets, x 
58,000.  Most cytoplasmic granules (arrows) contain arylsulfatase, especially at the granule 
periphery. 
a-Naphthylbutyrate esterase (sodium  fluoride inhibitable),  was  found on  the 
cell surface of LC (Fig. 5) but not on any Thy-1 + EC. Esterase was also noted on 
the surface of most keratinocytes, by EM, and in cytocentrifuge preparations by 
light microscopy. Fixation-resistant, endogenous peroxidase was not observed in 
any EC. We conclude that Thy-1 + and Ia  + epidermal leukocytes differ markedly 
from one another in cytologic features. 
Immunolabeling 
We  next applied  a  large  panel  of antibodies  (Table  I)  to  sheets  and  to  EC 
suspensions. When reactive reagents were identified, we did double labeling and 
immuno-EM to distinguish binding to LC or Thy-1 + EC. Both cell types expressed 
class I major histocompatibility antigens and the leukocyte common antigen, but 
otherwise their phenotypes were different (Table II). 
T Lymphocyte  Reagents.  Lyt-1, 2, 3 antigens were not detectable when we used 
mice reared under specific pathogen-free conditions and tested them within a 
week of shipment.  Conventionally reared mice had a  few Thy-1 + cells that also 
expressed  either  Lyt-1  and/or  Lyt-2,  but  these  likely  were  passenger  T  cells 
rather  than  resident  Thy-1 +  EC.  No  staining  was  observed  with  L3T4,  anti- ROMANI  ET  AL.  1375 
FIGURE 5.  EM a-napthylbutyrate  esterase combined with Thy-1 immunogold (C3H). (A) 
Two of three keratinocytes (K) have small amounts of esterase reaction product (area 1 is 
shown at higher power in insert 1), whereas Thy-l* EC are unreactive (area 2, insert 2). x 
6,600 and × 34,000. (B) LC (arrow, LC granule) show surface esterase reaction product, x 
32,000. (C) Thy-1  ÷ EC (gold labeled for Thy-1) are esterase negative on the cell surface and 
in the cytoplasmic  granules (arrows). × 32,000. 
interleukin 2 receptor, Qat-4 and 5, and four recently introduced T  cell alloan- 
tibodies, Lym-10, 18,  19, and 20. The thymus leukemia antigen (TL), originally 
detected on thymocytes and recently in epidermis (49), was  only found on LC 
and not Thy-1 ÷ EC (data not shown). 
Mononuclear Phagocyte  and Dendritic Cell Markers.  Previous studies (50,  51) 
identified the F4/80 anti-macrophage and 2.4G2 anti-Fc receptor antigens, but 
not 1.21J and M 1/70 anti-C3biR, on epidermal dendritic cells. We visualized all 
three  antigens,  but  only with  sensitive  three-step  techniques,  and  we  verified 
with double labeling that the antigens were expressed by all LC (Fig. 6). A  few 
Thy-1 + EC reacted strongly with  2.4G2.  These were typically found in groups 
close to hair follicles (Fig.  6), but were not T  cells since replicate sheets lacked 
Lyt-1 ÷ or Lyt-2  + cells.  33D1, an mAb specific for lymphoid dendritic cells, did 
not stain any EC. 
NK Cells.  Rabbit anti-asialo  GM~,  which reacts strongly with  NK cells (52, 1376  THY-I  +  MURINE  EPIDERMAL  CELLS ROMANI  ET  AL. 
TABLE  II 
Phenotype of Epidermal Langerhans  Cells, ~'hy-1  ÷ Cells, and Keratinocytes 
1377 
B or T  cell  Thy-1  L3T4;  Lym-1O,  TIB  145,  Ig  H9.25  TL  IL-2R 
markers  Lyt-123  18,  19, 22  H-11  146  lgpl00 
Langerhans cell  .......  +  - 
Thy-1 cell  +  ........ 
Keratinocyte  tr  ........ 
F4/80  M1/  asGM~  S100  Qa-4, 5;  33D1  I-J,  Diverse markers  Ia  FcR  C3biR  69.16  NK-1  B23.1 
Langerhans cell  +  +  +  +  -  +*  -  -  - 
Thy-1 cell  -  +]-  -  -  +  .... 
Keratinocyte  -  -  -  tr  ..... 
* 60-70%  positive; +/-,  <5% positive; tr, trace; asGMx, asialo GMt. 
53), stained Thy-1 + EC strongly but not Ia  + LC (Fig. 7). In suspension,  1-2% of 
EC expressed asialo GM~ and, by immuno-EM, all had the cytologic features of 
Thy-1 + EC (Fig.  7).  Qa-4 and  5, and  NK-1, which react with most but not all 
NK populations (54, 55), were not found on Thy-I ÷ EC. 
Diverse Markers.  Anti-B cell, anti-mast cell, H-11 (thymocytes), lgpl00 (most 
lymphocytes), and H9]25 (some lymphocytes) did not stain any EC.  M1/69.16, 
which reacts with a heat-stable antigen on most leukocytes, except for peripheral 
T  cells, reacted strongly with LC, weakly with most keratinocytes, but not with 
Thy-1 + EC.  Anti-S100  (56)  stained  many  LC but  no  Thy-1 + EC.  Functional 
studies (57) have suggested that epidermis contains  I-J  ÷ cells, but we could not 
kill  Thy-1 + EC  with  anti-I-J  and  complement.  Also,  we could not  find  I-J  by 
immunofluorescence  and  EM,  even after neuraminidase  treatment  (which en- 
hanced I-J-mediated killing in control T  cells as reported; 58). 
Discussion 
We have presented two types of evidence showing that Thy- 1  + murine EC are 
substantially different from LC.  At the light microscopy level, Thy-1 + and  Ia  ÷ 
cells  each  express  a  distinct  group  of antigens  (Table  II).  The  experiments 
included double-labeling approaches, which are necessary because the epidermis 
contains two types of dendritic ieukocytes and two types of dendritic nonleuko- 
cytes (melanocytes and Merkel cells). The fine structure of LC and Thy-1  ceils 
also differs,  particularly  with  respect to distinctive  granules.  LC have Birbeck 
granules and Thy, 1  + EC have membrane-bound granules with an electron-dense 
core and/or small internal  vesicles. All of these properties are apparent in intact 
epidermal sheets and in isolated suspensions. 
NK cells are  the  only  known  class of leukocyte resembling  Thy-1 + EC.  All 
Thy-1 + cells contain granules that are similar in structure and in their content 
FIGURE  6.  Double immunofluorescence of epidermal sheets (B6.H-2k mice) x  250.  MAC-1 
(a) and la (A*) antigens are found on the same cells. F4/80 (B) and la (B*) antigens overlap. 
F4/80 (C) and Thy-I (C*) are found on different cells (arrow, hair follicle). 2.4G2 (D) and Ia 
(D*) antigens stain the same cells (arrow,  hair).  2.4G2  (E)  stains several cells weakly (small 
arrows) and a  single cell strongly; the latter  (large arrowhead)  bears Thy-1  (E*).  Note  that 
Thy-1 stains keratinocytes in a  honeycomb pattern (see also C*). 1378  THY-1  ÷ MURINE  EPIDERMAL CELLS 
FIGURE  7.  Thy-I  + EC  (C3H) express asialo GMz: (A) Immuno-EM (two-step peroxidase 
method) showing that Thy-1 cells, with their characteristic granules (arrows), express asialo 
GM~, whereas keratinocytes (K) do not. × 15,200; insert, x 55,000. Scale bar -- 1 #m. Double 
immunofluorescence of C3H mice stained for Thy-1 (B) and asialo GMI (B*). The stains 
overlap, x 270. 
of aryl sulfatase to those found in large granular lymphocytes enriched for NK 
cells  and  in  certain  NK  and  cytolytic T  cell  lines  and  tumors  (59-63).  Small 
amounts  of Thy-1  are  found  on  subsets  of spleen  NK  cells  (55),  with  larger 
amounts on immature  NK cells (64) and certain  tissue NK cells (65,  66).  Both 
NK (52, 53) and Thy-1 + EC have readily detectable asialo GM~, but this marker ROMANI ET  AL.  1379 
is also found on  some T  cells (41)  and  macrophages  (67).  We did not detect 
epidermal killing of the NK target cell line, YAC, but, for that purpose, studies 
should be performed after stimulation  with interferon  or interleukin  2 and/or 
enrichment  procedures (only 0.5-2.0%  of EC express Thy-1).  The  distinctive 
phenotype of Thy-1 + cells (Table II) should be useful in devising techniques for 
their isolation from LC and keratinocytes. 
Summary 
Bone marrow-derived leukocytes of murine  epidermis can express two phe- 
notypes:  typical  Langerhans  cells,  which  are  Ia  + and  Thy-l-,  and  a  recently 
discovered  second  population  that  is  Thy-1 +  and  Ia-.  To  verify  that  these 
phenotypes are expressed by two different cell  types, and  to help  understand 
their  lineage and  function,  we have studied  morphology and  reactivity with a 
large  panel  of antibodies.  Dual  antibody  immunofluorescence  combined  with 
electron microscopy showed that Thy-1 + and Ia + cells were each distributed in a 
regular  fashion and formed adjacent dendritic  systems in or close to the basal 
layer.  Double-labeling  studies  with  anti-Ia  and  a  second monoclonal  antibody 
revealed that all  Langerhans  cells expressed F4/80 (macrophage),  Mac-1  (C3bi 
receptor),  and  2.4G2  (Fc receptor),  as well as the  thymus leukemia  (TL) and 
heat-stable  (M1.69/16)  antigens.  A  large  fraction  expressed  S100  and  all  ex- 
hibited  membrane  ATPase and  nonspecific esterase.  In  contrast,  Thy-I + cells 
lacked all these features of Langerhans cells, except that a minority were strongly 
reactive  with  2.4G2.  Thy-1 + cells also lacked differentiation  antigens  of most 
other  types of leukocytes,  except  they  were  rich  in  asialo  GM1.  By electron 
microscopy, Thy-1 + cells had cytoplasmic granules that were similar in structure 
and in their aryl sulfatase content to those previously described in natural killer 
cells. The granules were enlarged in beige mice, suggesting a  lysosomal origin, 
and  were present  in  mast cell-deficient  W/W  v mice,  indicating  no relation  to 
mast cells. We conclude that Thy-1 + epidermal cells are thoroughly distinct from 
Langerhans cells. On the basis of morphology and phenotype, they may represent 
a type of tissue natural  killer cell. 
Thy-1 + natural  killer cells are now being identified  in  several nonlymphoid 
sites, such as gut epithelium (66) and the livers of mice given adjuvants (65).  If 
Thy-1 + epidermal cells prove to be natural killer cells, it is noteworthy that they 
represent  a  resident  population  regularly  distributed  in  the  basal  layer  of all 
mouse  strains.  The  notion  that  Thy-1 + epidermal  cells are  immature  natural 
killer cells is intriguing in light of recent evidence that Ia  + Langerhans cells are 
also immature  with respect to accessory cell function.  The epidermis  may not 
have  the  functional  capacities  of a  lymphoid  organ,  but  it  could  contribute 
immature cells important for both natural and acquired resistance. 
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